These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders. Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609 [TBL] [Abstract][Full Text] [Related]
30. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Tefferi A Leukemia; 2010 Jun; 24(6):1128-38. PubMed ID: 20428194 [TBL] [Abstract][Full Text] [Related]
31. Mutational analysis in BCR-ABL-negative classic myeloproliferative neoplasms: impact on prognosis and therapeutic choices. Tefferi A Leuk Lymphoma; 2010 Apr; 51(4):576-82. PubMed ID: 20214447 [TBL] [Abstract][Full Text] [Related]
32. Histological and molecular classification of chronic myeloproliferative disorders in the age of JAK2: persistence of old questions despite new answers. Hussein K; Bock O; Kreipe H Pathobiology; 2007; 74(2):72-80. PubMed ID: 17587878 [TBL] [Abstract][Full Text] [Related]
34. [New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation]. Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC Ugeskr Laeger; 2006 Sep; 168(39):3299-303. PubMed ID: 17032592 [TBL] [Abstract][Full Text] [Related]
35. Mutations in the JAK2 and MPL genes and their correlation to clinical parameters in patients with chronic myeloproliferative disease. Bojko P; Abenhardt W; Schnittger S; Haferlach T Onkologie; 2009 Apr; 32(4):191-5. PubMed ID: 19372714 [TBL] [Abstract][Full Text] [Related]
36. The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay. Zhang SJ; Qiu HX; Li JY; Shi JY; Xu W Int J Lab Hematol; 2010 Aug; 32(4):381-6. PubMed ID: 20331763 [TBL] [Abstract][Full Text] [Related]
37. Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the Association for Molecular Pathology. Gong JZ; Cook JR; Greiner TC; Hedvat C; Hill CE; Lim MS; Longtine JA; Sabath D; Wang YL; J Mol Diagn; 2013 Nov; 15(6):733-44. PubMed ID: 23978506 [TBL] [Abstract][Full Text] [Related]